Company Overview and News

Stop missing out on important events!

Fintel provides real time notifications of important company events such as major investments (13D/G filings), insider trades (SEC form 4), and important SEC filings. Sign up and create your company alerts for free.

Headline News

LMNX / Luminex Corp. / Renaissance Technologies LLC - 3G (Passive Investment)

2018-02-15 sec.gov
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 LUMINEX CORPORATION ---------------------------------------------------------------------------- (Name of Issuer) Common Stock, par value $0.001 per share ---------------------------------------------------------------------------- (Title of Class of Securities) 55027E102 ---------------------------------------------------------------------------- (CUSIP Number) December

LMNX / Luminex Corp. / Renaissance Technologies LLC - 3G (Passive Investment)

2018-02-15 sec.gov
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 LUMINEX CORPORATION ---------------------------------------------------------------------------- (Name of Issuer) Common Stock, par value $0.001 per share ---------------------------------------------------------------------------- (Title of Class of Securities) 55027E102 ---------------------------------------------------------------------------- (CUSIP Number) December

LMNX / Luminex Corp. / RGM Capital, LLC - LMNX 13G (Passive Investment)

2018-02-15 sec.gov
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 LUMINEX CORPORATION -------------------------------------------------------------------------------- (Name of Issuer) Common Stock -------------------------------------------------------------------------------- (Title of Class of Securities) 55027E102 (CUSIP Number) December 31, 2017 -------------------------------------------------------------------------------- (Date of

LMNX / Luminex Corp. / RGM Capital, LLC - LMNX 13G (Passive Investment)

2018-02-15 sec.gov
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 LUMINEX CORPORATION -------------------------------------------------------------------------------- (Name of Issuer) Common Stock -------------------------------------------------------------------------------- (Title of Class of Securities) 55027E102 (CUSIP Number) December 31, 2017 -------------------------------------------------------------------------------- (Date of

Luminex (LMNX) Beats on Q4 Earnings & Revenues, Issues View

2018-02-13 zacks
Luminex Corporation (LMNX - Free Report) reported adjusted earnings of 17 cents per share in the fourth quarter of 2017, surpassing the Zacks Consensus Estimate of 9 cents by 88.9%. Adjusted earnings also increased 216.7% year over year. (3-0)

Luminex Corporation (LMNX) CEO Homi Shamir on Q4 2017 Results - Earnings Call Transcript

2018-02-13 seekingalpha
Good day ladies and gentlemen and welcome to Luminex Corporation, Fourth Quarter 2017 Earnings Conference Call. My name is Bryan and I will be your coordinator for today. (2-0)

LMNX / Luminex Corp. EXHIBIT 99.1

2018-02-12 sec.gov
Exhibit Exhibit 99.1 LUMINEX CORPORATION REPORTS FOURTH QUARTER AND FULL YEAR 2017 RESULTS AUSTIN, Texas (February 12, 2018) - Luminex Corporation (NASDAQ:LMNX) today announced financial results for the fourth quarter and full-year 2017. Financial and operating highlights for the quarter and full-year include: • Fourth quarter and full-year 2017 consolidated revenue was $78.2 million and $306.6 million, an increase of 8% and 13%, respectively, compared to the fourth quarter and full-year 2016.

LMNX / Luminex Corp. 8-K (Current Report)

2018-02-12 sec.gov
Document UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 12, 2018 (February 12, 2018) LUMINEX CORPORATION (Exact name of registrant as specified in its charter) DELAWARE   000-30109   74-2747608 (State or other jurisdiction of incorporation)   (Commission File Number)   (IRS Employer Identification No.

LMNX / Luminex Corp. / VANGUARD GROUP INC - 3G/A (Passive Investment)

2018-02-09 sec.gov
luminexcorp.htm - Generated by SEC Publisher for SEC Filing SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549   Schedule 13G   Under the Securities Exchange Act of 1934 (Amendment No.: 5 )*       Name of issuer:  Luminex Corp     Title of Class of Securities:  Common Stock     CUSIP Number:  55027E102     Date of Event Which Requires Filing of this Statement: December 31, 2017   Check the appropriate box to designate the rule pursuant to which this Schedule is filed:   (X) Rule 13d-1(b)

LMNX / Luminex Corp. / VANGUARD GROUP INC - 3G/A (Passive Investment)

2018-02-09 sec.gov
luminexcorp.htm - Generated by SEC Publisher for SEC Filing SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549   Schedule 13G   Under the Securities Exchange Act of 1934 (Amendment No.: 5 )*       Name of issuer:  Luminex Corp     Title of Class of Securities:  Common Stock     CUSIP Number:  55027E102     Date of Event Which Requires Filing of this Statement: December 31, 2017   Check the appropriate box to designate the rule pursuant to which this Schedule is filed:   (X) Rule 13d-1(b)

ResMed (RMD) Rides on Product Launches, Robust Global Growth

2018-01-29 zacks
On Jan 25, 2018, we issued an updated research report on leading medical devices company, ResMed Inc. (RMD - Free Report) . The stock carries a Zacks Rank #2 (Buy). (10-1)

What's in Store for Becton, Dickinson (BDX) in Q1 Earnings?

2018-01-25 zacks
Becton, Dickinson and Company’s (BDX - Free Report) first-quarter fiscal 2017 results, scheduled for release on Feb 6, are expected to show sluggishness in BD Medical — one of the major revenue components. While this can majorly dampen earnings in the first quarter, an expected improvement in revenues in other segments will help the company generate solid results. (15-0)

Mckesson (MCK) to Report Q3 Earnings: A Beat in the Cards?

2018-01-25 zacks
McKesson Corporation (MCK - Free Report) is scheduled to release third-quarter fiscal 2018 results on Feb 1, before the market opens. (19-0)

The Ideal Stock Evaluation System?

2018-01-22 seekingalpha
About two and a half years ago, I had a revelation. I’d been losing money for years, choosing the wrong stocks, buying and selling them at the wrong times. But I suddenly realized that the key to success in the stock market is not just screening stocks on a few factors but instead to systematically evaluate every stock from as many angles as possible before buying it. Since I put my initial evaluation system in place around Halloween 2015, my compound annual returns have been 47%--a total growth of 135% in 27 months. (209-3)

LMNX / Luminex Corp. / BlackRock Inc. - 3G/A (Passive Investment)

2018-01-19 sec.gov
us55027e1029_011718.txt SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No: 10) LUMINEX CORPORATION -------------------------------------------------------- (Name of Issuer) Common Stock -------------------------------------------------------- (Title of Class of Securities) 55027E102 -------------------------------------------------------- (CUSIP Number) December 31, 2017 -------------------------------------------------


CUSIP: 55027E102